MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
BioLife Solutions General and Administrative Expenses 2011-2026 | BLFS
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses BioLife Solutions
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.5 M | 43.3 M | 33.3 M | 33.7 M | 15.3 M | 8.89 M | 5.95 M | 4.52 M | 4.59 M | 2.64 B | 3.97 M | 2.72 M | 2.15 M | 1.83 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.64 B | 1.83 M | 203 M |
Quarterly General and Administrative Expenses BioLife Solutions
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.1 M | 11.4 M | 11.5 M | - | 9.33 M | 9.32 M | 10.4 M | - | 10.8 M | 13.5 M | 14.8 M | - | 11.9 M | 11.7 M | 11.5 M | - | 10.1 M | 7.15 M | 4.83 M | - | 3.5 M | 3.28 M | 3.14 M | - | 2.35 M | 2.21 M | 2.15 M | - | 1.46 M | 1.39 M | 1.35 M | - | 1.12 M | 1.08 M | 1.1 M | - | 1.04 M | 1.26 M | 1.34 M | - | 1.26 M | 1.03 M | 1.22 M | - | 1.01 M | 970 K | 864 K | - | 630 K | 602 K | 624 K | - | 488 K | 475 K | 479 K | - | 500 K | 401 K | 454 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 14.8 M | 401 K | 4.43 M |
General and Administrative Expenses of other stocks in the Medical instruments industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
23.2 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
2.97 B | $ 19.81 | -1.39 % | $ 10.1 B | USA |
 |
Luminex Corporation
LMNX
|
140 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
3.73 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
62.8 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
198 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
941 M | - | -0.05 % | $ 10.3 B | USA |
 |
ICU Medical
ICUI
|
639 M | $ 151.44 | 1.03 % | $ 3.69 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
671 M | - | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
8.79 M | $ 9.32 | 7.13 % | $ 188 M | USA |
 |
Alcon
ALC
|
251 M | $ 79.49 | -1.84 % | $ 40.4 B |  Schweiz |
 |
InfuSystem Holdings
INFU
|
46.1 M | $ 8.11 | -1.82 % | $ 167 M | USA |
 |
AtriCure
ATRC
|
291 M | $ 37.22 | 0.79 % | $ 1.75 B | USA |
 |
electroCore
ECOR
|
27.2 M | $ 6.63 | -0.45 % | $ 36.6 K | USA |
 |
Haemonetics Corporation
HAE
|
437 M | $ 65.95 | -1.07 % | $ 3.32 B | USA |
 |
Merit Medical Systems
MMSI
|
400 M | $ 81.57 | 0.59 % | $ 4.75 B | USA |
 |
AngioDynamics
ANGO
|
42.1 M | $ 10.43 | 0.68 % | $ 426 M | USA |
 |
The Cooper Companies
COO
|
1.63 B | $ 80.78 | -0.74 % | $ 16.1 B | USA |
 |
Harvard Bioscience
HBIO
|
22.8 M | $ 0.5 | -0.06 % | $ 21.2 M | USA |
 |
OraSure Technologies
OSUR
|
46.2 M | $ 2.93 | 5.02 % | $ 218 M | USA |
 |
Glaukos Corporation
GKOS
|
224 M | $ 118.23 | -1.01 % | $ 5.73 B | USA |
 |
Isoray
ISR
|
26.6 M | - | 0.03 % | $ 108 M | USA |
 |
Repro Med Systems
KRMD
|
20.4 M | $ 5.68 | 5.38 % | $ 259 M | USA |
 |
Pulse Biosciences
PLSE
|
15.8 M | $ 13.72 | -0.8 % | $ 659 M | USA |
 |
iRhythm Technologies
IRTC
|
419 M | $ 156.97 | 1.59 % | $ 4.9 B | USA |
 |
LeMaitre Vascular
LMAT
|
36.3 M | $ 86.12 | 1.35 % | $ 1.93 B | USA |
 |
Masimo Corporation
MASI
|
744 M | $ 137.98 | 0.47 % | $ 7.35 B | USA |
 |
Intuitive Surgical
ISRG
|
2.14 B | $ 498.86 | -1.06 % | $ 177 B | USA |
 |
STERIS plc
STE
|
1.33 B | $ 264.16 | 0.54 % | $ 26 B | USA |
 |
Microbot Medical
MBOT
|
4.13 M | $ 1.81 | 0.28 % | $ 18.5 M |  Israel |
 |
Nephros
NEPH
|
8.91 M | $ 4.6 | 6.61 % | $ 47.8 M | USA |
 |
Milestone Scientific
MLSS
|
12.3 M | $ 0.26 | -6.09 % | $ 20.7 M | USA |
 |
Utah Medical Products
UTMD
|
11 M | $ 61.52 | 0.75 % | $ 223 M | USA |
 |
NeuroMetrix
NURO
|
6.33 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.16 B | $ 23.17 | -1.26 % | $ 3.99 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.6 B | $ 12.23 | -1.96 % | $ 2.49 B | USA |
 |
Pro-Dex
PDEX
|
4.84 M | $ 39.46 | 0.59 % | $ 130 M | USA |
 |
Predictive Oncology
POAI
|
7.42 M | - | - | $ 31.1 M | USA |
 |
Becton, Dickinson and Company
BDX
|
5.28 B | $ 202.29 | -0.62 % | $ 58.2 B | USA |
 |
Repligen Corporation
RGEN
|
219 M | $ 150.74 | 0.91 % | $ 8.4 M | USA |
 |
ResMed
RMD
|
739 M | $ 253.87 | -1.72 % | $ 37.1 B | USA |
 |
Stereotaxis
STXS
|
14 M | $ 2.23 | 1.6 % | $ 180 M | USA |
 |
Retractable Technologies
RVP
|
13.6 M | $ 0.7 | - | $ 21 M | USA |
 |
STAAR Surgical Company
STAA
|
89.9 M | $ 18.05 | -4.75 % | $ 887 M | USA |
 |
Teleflex Incorporated
TFX
|
995 M | $ 103.79 | -0.57 % | $ 4.86 B | USA |
 |
West Pharmaceutical Services
WST
|
338 M | $ 235.82 | 2.01 % | $ 17.2 B | USA |